no I couldn’t find any data in company presentations about pain relief with device. Maybe we’ll need to wait for further trial updates but agree with comments about confounders and placebo effects. Went into OSL website a couple of days ago to look for Oncosil device official product label/ information /package insert or equivalent (like Sirtex has on its site) as this may have been informative about what BSI has approved, but couldn’t find it. Seems strange not to have it if device licensed for sale in Europe. I did note they call the device an “adjuvant” treatment. That doesn’t make sense based on how it’s used; perhaps they don’t really understand what adjuvant means in oncology. But Will also hold for now.
OSL Price at posting:
12.5¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)